Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5626 AL 5640

Enhancing Reliability of Automated Remote Parkinson's Assessments: Real-World Video Quality Challenges

Irani A, Majdolashrafi S, Grundy M, Park KW, Mi T, Diab H, Ayala J, Mirian MS, McKeown MJ.

Mov Disord Clin Pract. 2026 Feb;13(2):572-574. doi: 10.1002/mdc3.70358. Epub 2025 Sep 12.

PGRN Manifesting as Parkinson's Disease: Counseling and Treatment Implications

Makrygianni M, Beratis IN, Giagkou N, Papageorgiou S, Stefanis L, Stamelou M.

Mov Disord Clin Pract. 2026 Feb;13(2):583-584. doi: 10.1002/mdc3.70328. Epub 2025 Sep 15.

Reply: "PGRN Manifesting as Parkinson's Disease: Counseling and Treatment Implications"

Antonini A, Bonato G, Carecchio M.

Mov Disord Clin Pract. 2026 Feb;13(2):585-586. doi: 10.1002/mdc3.70326. Epub 2025 Sep 15.

Fluorescent probes for α-synuclein biomarkers: Innovations in early diagnosis and therapeutic monitoring of Parkinson's disease

Li Q, Song S, Song Z, Shah PT, Zhang Q, Yang Y, Tan X, Wang J, Wu Z.

Clin Chim Acta. 2026 Jan 15;579:120612. doi: 10.1016/j.cca.2025.120612. Epub 2025 Sep 15.

Associations of diet-derived short chain fatty acids with Parkinson's disease: a systematic review and meta-analysis

An K, Qu Y, Li J, Wang D, Mao Z, Xue Z.

Nutr Neurosci. 2026 Feb;29(2):248-266. doi: 10.1080/1028415X.2025.2558119. Epub 2025 Sep 17.

Risk factors for mild cognitive impairment in Parkinson disease: a systematic review and meta-analysis

Zhang Y, Chen F, Ren F.

Mol Cell Biochem. 2026 Jan;481(1):1-14. doi: 10.1007/s11010-025-05392-y. Epub 2025 Sep 18.

Neuroinflammation and Disease: Pathways and Opportunities

Hoffman O, Varvel NH, Roopra AS, Dingledine R.

Annu Rev Pharmacol Toxicol. 2026 Jan;66(1):541-563. doi: 10.1146/annurev-pharmtox-062124-043519. Epub 2025 Sep 18.

Comment on "Deep inspiration as a diagnostic maneuver to differentiate accessory-pathway-induced ST elevation from inferior myocardial infarction"

Zhan ZQ.

J Electrocardiol. 2026 Jan-Feb;94:154133. doi: 10.1016/j.jelectrocard.2025.154133. Epub 2025 Sep 13.

Role of Microglial Dysfunction in Parkinson's Disease: From Multifactorial Causes to Neurodegeneration

Xu Y, Han T, Wu Y, Liu H, Hou K, An Z, Li Y, Zhu C, Wang S, Wei J.

Neurosci Bull. 2026 Feb;42(2):439-459. doi: 10.1007/s12264-025-01505-1. Epub 2025 Sep 19.

Are amyloid-based materials conducive to tissue engineering?

Patel K, Maji SK.

Trends Biotechnol. 2026 Apr;44(4):921-939. doi: 10.1016/j.tibtech.2025.08.009. Epub 2025 Sep 19.

Refining Video Urodynamic Study-Based Differentiation of Parkinson's Disease and Multiple System Atrophy: Methodological Gaps and Interdisciplinary Directions

Che K, Lin K, Li S.

Mov Disord Clin Pract. 2026 Feb;13(2):589-590. doi: 10.1002/mdc3.70351. Epub 2025 Sep 23.

N-acetylcysteine for Parkinson's disease: a translational systematic review of mechanistic and early clinical data

Mohammad A, Ibrahim M, Akram M, Mohsin H, Imran MT, Khan Alizai HN.

Neurodegener Dis Manag. 2026 Oct;16(5):631-642. doi: 10.1080/17582024.2025.2563489. Epub 2025 Sep 24.

Is tau pathology a relevant factor in neuronal damage induced by alcohol and other drugs?

Olesen MA, Ancía A, Quintanilla RA.

Biochim Biophys Acta Mol Basis Dis. 2026 Jan;1872(1):168059. doi: 10.1016/j.bbadis.2025.168059. Epub 2025 Sep 22.

Novel Interdisciplinary Gastroenterology and Parkinson's Disease Clinic in a Parkinson's Center of Excellence

Arena M, Safarpour D, Bryant A, Ramirez-Zamora A, Laberee N, Smouse A, Diamond S.

Mov Disord Clin Pract. 2026 Mar;13(3):623-630. doi: 10.1002/mdc3.70365. Epub 2025 Sep 26.

Further Considerations on the Research of Parkinson's Disease-Related Chronic Pain

Hu C.

Mov Disord Clin Pract. 2026 Mar;13(3):849-850. doi: 10.1002/mdc3.70373. Epub 2025 Sep 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias